| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |